Urate Biology and Biochemistry: A Year in Review 2022
Gout, Urate, and Crystal Deposition Disease · 2023
DOI: 10.3390/gucdd1030011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gout, Urate, and Crystal Deposition Disease, 2023. Verfasst von Rachel D. King und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The past year generated significant change and advancement of the urate field with novel insights regarding the role of uric acid (UA) in multiple pathophysiologic processes from gout to COVID-19. While these contributions continue to move the field forward, the basic biochemistry and biology of UA is often overlooked, being lost in the shadow of clinical associations and omics. However, the seminal impact of UA begins with biochemistry and the associated interplay with cell biology. In these basic reactions and resultant impacts on physiology, UA mediates its influence on clinical outcomes. As such, this review focuses on published advances in UA biochemistry and biology in 2022 and associates these advances with downstream consequences.
Zitieren
APA
King, R. D., & Kelley, E. E. (2023). Urate Biology and Biochemistry: A Year in Review 2022. Gout, Urate, and Crystal Deposition Disease. https://doi.org/10.3390/gucdd1030011
Vancouver
King RD, Kelley EE. Urate Biology and Biochemistry: A Year in Review 2022. Gout, Urate, and Crystal Deposition Disease. 2023. doi:10.3390/gucdd1030011
BibTeX
@article{King2023,
author = {King, Rachel D. and Kelley, Eric E.},
title = {Urate Biology and Biochemistry: A Year in Review 2022},
journal = {Gout, Urate, and Crystal Deposition Disease},
year = {2023},
doi = {10.3390/gucdd1030011}
}
EUVIMED